Close

Concert Pharma (CNCE) Misses Q1 EPS by 18c

May 5, 2016 7:07 AM EDT

Concert Pharma (NASDAQ: CNCE) reported Q1 EPS of ($0.63), $0.18 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Concert Pharma (CNCE) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings